New Senior Executives appointed at Sanofi
- Details
- Category: Sanofi
![Sanofi Sanofi](/images/stories/logo/sanofi.gif)
Bristol-Myers Squibb to Acquire Amira Pharmaceuticals
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
FDA approves new medicine BRILINTA (ticagrelor) for use in the US
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Pfizer To Acquire Icagen
- Details
- Category: Pfizer
![Pfizer Pfizer](/images/stories/logo/pfizer_b.gif)
FDA Advisory Committee Makes Recommendation on Investigational Compound Dapagliflozin
- Details
- Category: Bristol-Myers Squibb
![Bristol-Myers Squibb Bristol-Myers Squibb](/images/stories/logo/bms.gif)
Novartis delivers strong financial results and four major approvals
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
Abbott Confirms Long-Term Commitment to HIV Care
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
More Pharma News ...
- Novartis begins shipment of Fluvirin® seasonal influenza vaccine to US customers
- XGEVA® (Denosumab) Granted Marketing Authorization in the European Union
- Roche provides update from FDA hearing on Avastin for metastatic breast cancer
- Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
- Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab in Multiple Sclerosis
- Boehringer Ingelheim and Ashoka's Changemakers Launch "Making More Health" Competition
- Phase III trial of Novartis drug Afinitor® met primary endpoint